Endometrial Endometrioid Adenocarcinoma

Endometrial Endometrioid Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

42 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 8
Ph III recruiting: 2
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05498597	AMT-151 in Patients With Selected Advanced Solid Tumours	unknown	Phase 1	30	Multitude Therapeutics Inc.INDUSTRY	2	Oct 19, 2023	clinicaltrials
NCT00492778	Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer	unknown	Phase 2	165	GOG FoundationNETWORK	2	Mar 29, 2023	clinicaltrials